Maculaser is a clinical phase startup company that develops novel medical technology to prevent blindness. Our mission is to provide safe and effective laser treatment for macular disorders, which affect millions of people worldwide.
Our roots are deeply in science and technology. Personalization of ophthalmic laser therapies with our electroretinography-based dosimetry constitutes the core of our innovation. The targeted diseases include diabetic macular edema and age-related macular degeneration; we are well financed to move towards the first clinical trial.